Center for Hematology/Oncology of S. Michigan

Jackson, Michigan 49201

0 studies enrolling now · 4 studies all time

What they study most

Head and Neck Cancer, Metastatic Breast Cancer, Myelodysplastic Syndromes, Prostate Cancer

Studies at this site

• Azacitidine and Erythropoietin Versus Azacitidine Alone for Patients With Low-Risk Myelodysplastic Syndromes — Stopped early
• Pemetrexed as Second-Line Therapy in Treating Patients With Hormone Refractory Prostate Cancer — Completed
• Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast Cancer — Stopped early
• Docetaxel and Capecitabine for First Line Treatment of Metastatic Squamous Cell Carcinoma of the Head & Neck — Stopped early